170
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Functional polymorphisms in TBX21 and HLX are associated with development and prognosis of Graves' disease

, , , , , , & show all
Pages 129-136 | Received 12 Jan 2011, Accepted 06 Sep 2011, Published online: 21 Oct 2011

References

  • Iwatani Y, Watanabe M. 1999. Normal mechanisms for self-tolerance. In: Volpe R. editors. Autoimmune endocrinopathies. Totawa, NJ: Humana Press, Inc.1–30.
  • Davies TF. 2000. Pathogenesis of Graves' disease. In: Braverman LE, Utiger RD. editors. The thyroid: A fundamental and clinical text. Philadelphia, PA: Lippincott Williams & Wilkins518–531.
  • Jacobson EM, Tomer Y. The genetic basis of thyroid autoimmunity. Thyroid. 2007; 17 10: 949–961.
  • Amino N, Hagen SR, Yamada N, Refetoff S. Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: Its usefulness in the diagnosis of autoimmune thyroid diseases. Clin Endocrinol (Oxf.). 1976; 5 2: 115–125.
  • Yoshida H, Amino N, Yagawa K, Uemura K, Satoh M, Miyai K, Kumahara Y. Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: Studies of seventy autopsied cases. J Clin Endocrinol Metab. 1978; 46 6: 859–862.
  • Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996; 383 6603: 787–793.
  • Mosmann TF, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. 1996; 17 3: 138–146.
  • Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, Bloom BR. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science. 1991; 254 5029: 279–282.
  • Yano S, Sone S, Nishioka Y, Mukaida N, Matsushima K, Ogura T. Differential effects of anti-inflammatory cytokines (IL-4, IL-10 and IL-13) on tumoricidal and chemotactic properties of human monocytes induced by monocyte chemotactic and activating factor. J Leukoc Biol. 1995; 57 2: 303–309.
  • Nanba T, Watanabe M, Inoue N, Iwatani Y. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. Thyroid. 2009; 19 5: 495–501.
  • Ito C, Watanabe M, Okuda N, Watanabe C, Iwatani Y. Association between the severity of Hashimoto's disease and the functional +874A/T polymorphism in the interferon-gamma gene. Endocr J. 2006; 53 4: 473–478.
  • Nanba T, Watanabe M, Akamizu T, Iwatani Y. The -590CC genotype in the IL4 gene as a strong predictive factor for the development of hypothyroidism in Hashimoto disease. Clin Chem. 2008; 54 3: 621–623.
  • Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000; 100 6: 655–669.
  • Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 1997; 89 4: 587–596.
  • Mowen KA, Glimcher LH. Signaling pathways in Th2 development. Immunol Rev. 2004; 202:203–222.
  • Rautajoki KJ, Kylaniemi MK, Raghav SK, Rao K, Lahesmaa R. An insight into molecular mechanisms of human T helper cell differentiation. Ann Med. 2008; 40 5: 322–335.
  • Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annu Rev Immunol. 2010; 28:445–489.
  • Kaneko T, Hosokawa H, Yamashita M, Wang CR, Hasegawa A, Kimura MY, Kitajiama M, Kimura F, Miyazaki M, Nakayama T. Chromatin remodeling at the Th2 cytokine gene loci in human type 2 helper T cells. Mol Immunol. 2007; 44 9: 2249–2256.
  • Suttner K, Rosenstiel P, Depner M, Schedel M, Pinto LA, Ruether A, Adamski J, Klopp N, Illig T, Vogelberg C, Schreiber S, von Mutius E, Kabesch M. TBX21 gene variants increase childhood asthma risk in combination with HLX1 variants. J Allergy Clin Immunol. 2009; 123 5: 1062–1068.
  • Akahoshi M, Obara K, Hirota T, Matsuda A, Hasegawa K, Takahashi N, Shimizu M, Nakashima K, Cheng L, Doi S, Fujiwara H, Miyatake A, Fujita K, Higashi N, Taniguchi M, Enomoto T, Mao XQ, Nakashima H, Adra CN, Nakamura Y, Tamari M, Shirakawa T. Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma. Hum Genet. 2005; 117 1: 16–26.
  • Mullen AC, Hutchins AS, High FA, Lee HW, Sykes KJ, Chodosh LA, Reiner SL. Hlx is induced by and genetically interacts with T-bet to promote heritable T(H)1 gene induction. Nat Immunol. 2002; 3 7: 652–658.
  • Mikhalkevich N, Becknell B, Caligiuri MA, Bates MD, Harvey R, Zheng WP. Responsiveness of naive CD4 T cells to polarizing cytokine determines the ratio of Th1 and Th2 cell differentiation. J Immunol. 2006; 176 3: 1553–1560.
  • Zheng WP, Zhao Q, Zhao X, Li B, Hubank M, Schatz DG, Flavell RA. Up-regulation of Hlx in immature Th cells induces IFN-gamma expression. J Immunol. 2004; 172 1: 114–122.
  • Suttner K, Ruoss I, Rosenstiel P, Depner M, Pinto LA, Schedel M, Adamski J, Illig T, Schreiber S, von Mutius E, Kabesch M. HLX1 gene variants influence the development of childhood asthma. J Allergy Clin Immunol. 2009; 123 1: 82–88.
  • Chakir H, Wang H, Lefebvre DE, Webb J, Scott FW. T-bet/GATA-3 ratio as a measure of the Th1/Th2 cytokine profile in mixed cell populations: Predominant role of GATA-3. J Immunol Methods. 2003; 278 1–2: 157–169.
  • Ho IC, Vorhees P, Marin N, Oakley BK, Tsai SF, Orkin SH, Leiden JM. Human GATA-3: A lineage-restricted transcription factor that regulates the expression of the T cell receptor alpha gene. EMBO J. 1991; 10 5: 1187–1192.
  • Oosterwegel M, Timmerman J, Leiden J, Clevers H. Expression of GATA-3 during lymphocyte differentiation and mouse embryogenesis. Dev Immunol. 1992; 3 1: 1–11.
  • Ting CN, Olson MC, Barton KP, Leiden JM. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature. 1996; 384 6608: 474–478.
  • Joulin V, Bories D, Eleouet JF, Labastie MC, Chretien S, Mattei MG, Romeo PH. A T-cell specific TCR delta DNA binding protein is a member of the human GATA family. EMBO J. 1991; 10 7: 1809–1816.
  • Labastie MC, Bories D, Chabret C, Gregoire JM, Chretien S, Romeo PH. Structure and expression of the human GATA3 gene. Genomics. 1994; 21 1: 1–6.
  • Asnagli H, Afkarian M, Murphy KM. Cutting edge: Identification of an alternative GATA-3 promoter directing tissue-specific gene expression in mouse and human. J Immunol. 2002; 168 9: 4268–4271.
  • Yu Q, Sharma A, Oh SY, Moon HG, Hossain MZ, Salay TM, Leeds KE, Du H, Wu B, Waterman ML, Zhu Z, Sen JM. T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma. Nat Immunol. 2009; 10 9: 992–999.
  • Watanabe M, Yamamoto N, Maruoka H, Tamai H, Matsuzuka F, Miyauchi A, Iwatani Y. Independent involvement of CD8+ CD25+ cells and thyroid autoantibodies in disease severity of Hashimoto's disease. Thyroid. 2002; 12 9: 801–808.
  • Santoh T, Watanabe M, Kuroda S, Ueda D, Iwatani Y. Ratio of serum IgG3 to total IgG concentration and goiter size are independent factors in intractability of Graves' disease. Endocr J. 2007; 54 6: 887–894.
  • Zhang L, Wang X, Han D, Duan H, Zhao Y. Association of single nucleotide polymorphisms in GATA-3 with allergic rhinitis. Acta Otolaryngol. 2009; 129 2: 190–194.
  • Hwang ES. Transcriptional regulation of T helper 17 cell differentiation. Yonsei Med J. 2010; 51 4: 484–491.
  • Chekmenev D, Haid C, Kel AP-Match URL http://www.gene-regulation.com/pub/programs.html#pmatch.
  • Yamada H, Watanabe M, Nanba T, Akamizu T, Iwatani Y. The +869T/C polymorphism in the transforming growth factor-beta1 gene is associated with the severity and intractability of autoimmune thyroid disease. Clin Exp Immunol. 2008; 151 3: 379–382.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.